A new survey finds almost 80 percent of American biotech companies contract with Chinese firms and decoupling from them could be a long game. Some say switching partners could take up to eight years.
79 Percent of US Biotech Firms Contract With Chinese Firms
By Juliet Song
China in Focus Weekly Newsletter
Find out what's really going on in China
Success! You are now subscribed.
By registering for the newsletter, you agree to the Privacy Policy.